From: Cyr61 Expression is associated with prognosis in patients with colorectal cancer
Clincopathological factors | Cyr61 | Total (%) | p | |
---|---|---|---|---|
Positive N = 157 (%) | Negative N = 94 (%) | |||
Age, years, mean (SD) | 62.2 (12.2) | 65.2 (11.5) | 63.3 (12.0) | 0.061 |
Sex | Â | Â | Â | 0.296 |
 Male | 88 (56.1) | 59 (62.8) | 147 (58.6) |  |
 Female | 69 (43.9) | 35 (37.2) | 104 (41.4) |  |
pT stage | Â | Â | Â | 0.021 |
 1 | 8 (5.1) | 2 (2.1) | 10 (4.0) |  |
 2 | 20 (12.7) | 21 (22.3) | 41 (16.3) |  |
 3 | 105 (66.9) | 66 (70.2) | 171 (68.1) |  |
 4 | 24 (15.3) | 5 (5.3) | 29 (11.6) |  |
pN stage | Â | Â | Â | 0.006 |
 0 | 73 (46.5) | 63 (67.0) | 136 (54.2) |  |
 1 | 56 (35.7) | 19 (20.2) | 75 (29.9) |  |
 2 | 28 (17.8) | 12 (12.8) | 40 (15.9) |  |
Vascular invasion | Â | Â | Â | 0.700 |
 0 | 136 (86.6) | 83 (88.3) | 219 (87.3) |  |
 1 | 21 (13.4) | 11 (11.7) | 32 (12.7) |  |
Lymphatic invasion | Â | Â | Â | 0.563 |
 0 | 131 (83.4) | 81 (86.2) | 212 (84.5) |  |
 1 | 26 (16.6) | 13 (13.8) | 39 (15.5) |  |
TNM stage | Â | Â | Â | 0.001 |
 I | 17 (10.8) | 18 (19.1) | 35 (13.9) |  |
 II | 51 (32.5) | 47 (50.0) | 98 (39.0) |  |
 III | 79 (50.3) | 26 (27.7) | 105 (41.8) |  |
 IV | 10 (6.4) | 3 (3.2) | 13 (5.2) |  |